Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells

被引:75
作者
Distler, JHW
Jüngel, A
Caretto, D
Schulze-Horsel, U
Kowal-Bielecka, O
Gay, RE
Michel, BA
Müller-Ladner, U
Kalden, JR
Gay, S
Distler, O [1 ]
机构
[1] Univ Zurich Hosp, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
[3] Med Univ Bialystok, Bialystok, Poland
[4] Univ Giessen, D-35390 Giessen, Germany
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 01期
关键词
D O I
10.1002/art.21497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Monocyte chemoattractant protein I (MCP-1; CCL2) has been implicated-in the pathogenesis of fibrotic diseases and is up-regulated in patients with systemic sclerosis (SSc). The aim of the present study was to examine the mechanisms by which MCP-1 mediates its profibrotic effects in the setting of SSc. Methods. The expression of receptors for MCP-1 on dermal fibroblasts was analyzed by real-time polymerase chain reaction and fluorescence-activated cell sorting. The ability of extracellular matrix proteins to bind and release MCP-1 was quantified by enzyme-linked immunosorbent assay. Th0 cells were isolated using a magnetic-activated cell sorting system and were stimulated twice in the presence of MCP-1. The synthesis of collagen was measured using the Sircol collagen assay kit. Results. The glycosaminoglycan chondroitin sulfate, but not fibronectin or collagens, bound and released MCP-1 in a time-dependent manner. MCP-1 that was released from chondroitin sulfate induced the differentiation of interleukin-4 (IL-4)-producing T cells in a dose-dependent manner. In turn, dermal fibroblasts from patients with SSc expressed IL-4 receptor, and stimulation with IL-4 significantly increased the production of collagen in dermal fibroblasts. In contrast, CCR2a and CCR2b, as well as D6 and US28 (other potential receptors of MCP-1), were not detectable in SSc and normal fibroblasts, and their expression was not induced by platelet-derived growth factor, IL-1 beta, or IL-4. In addition, MCP-1 had no direct effects on collagen production by fibroblasts. Conclusion. MCP-1 has no direct effects on dermal fibroblasts but contributes to fibrosis in patients with SSc by inducing the differentiation of IL-4-producing T cells. Because MCP-1 has both proinflammatory and profibrotic effects, pharmacologic targeting of MCP-1 could be a promising therapeutic approach in SSc.
引用
收藏
页码:214 / 225
页数:12
相关论文
共 50 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]  
BUCKINGHAM RB, 1983, J LAB CLIN MED, V101, P659
[3]   Lysine 58 and histidine 66 at the C-terminal α-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding [J].
Chakravarty, L ;
Rogers, L ;
Quach, T ;
Breckenridge, S ;
Kolattukudy, PE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29641-29647
[4]   Chemokines in the pathogenesis of vascular disease [J].
Charo, IF ;
Taubman, MB .
CIRCULATION RESEARCH, 2004, 95 (09) :858-866
[5]   Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α [J].
Chizzolini, C ;
Parel, Y ;
De Luca, C ;
Tyndall, A ;
Åkesson, A ;
Scheja, A ;
Dayer, JM .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2593-2604
[6]   Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC) [J].
Dawson, TC ;
Lentsch, AB ;
Wang, ZX ;
Cowhig, JE ;
Rot, A ;
Maeda, N ;
Peiper, SC .
BLOOD, 2000, 96 (05) :1681-1684
[7]  
Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293
[8]   Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-κB and simian virus 40 promoter factor 1 pathways [J].
Distler, JHW ;
Hagen, C ;
Hirth, A ;
Müller-Ladner, U ;
Lorenz, HM ;
del Rosso, A ;
Michel, BA ;
Gay, RE ;
Nanagara, R ;
Nishioka, K ;
Matucci-Cerinic, M ;
Kalden, JR ;
Gay, S ;
Distler, O .
MOLECULAR PHARMACOLOGY, 2004, 65 (02) :389-399
[9]  
Distler O, 2001, ARTHRITIS RHEUM-US, V44, P2665, DOI 10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO
[10]  
2-S